<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">SDS</journal-id><journal-title-group><journal-title>Social Development Studies</journal-title></journal-title-group><issn>3083-3876</issn><eissn>3083-3868</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/sds.v2i1.14140</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>A Comparative Study on the R&amp;D Models and Industrialization Performance of Biomaterial Enterprises in the Context of Similar Technologies but Different Systems: A Dual Case Study of Cathay Biotech and Genomatica</title><url>https://artdesignp.com/journal/SDS/2/1/10.26689/sds.v2i1.14140</url><author>ZhouLiling</author><pub-date pub-type="publication-year"><year>2026</year></pub-date><volume>2</volume><issue>1</issue><history><date date-type="pub"><published-time>2026-03-11</published-time></date></history><abstract>Both Cathay Biotech and Genomatica in the United States utilize synthetic biology routes to produce long-chain dicarboxylic acids, sharing similar technological approaches. However, the two companies differ in their accounting treatment of R&amp;amp;D expenditures regarding capitalization and in the assessment mechanisms for government subsidies. These differences have, to a certain extent, led the two enterprises to choose distinct R&amp;amp;D models. From the perspective of innovation performance, Cathay Biotech’s autonomous vertical integration innovation model outperforms Genomatica’s open collaboration innovation model in terms of shortening the trial-and-error cycle and improving product gross profit margins.</abstract><keywords>Biomaterials; R&amp;D models; Long-chain dicarboxylic acids; Open innovation; Vertical integration</keywords></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Chesbrough H, 2003, Open Innovation: The New Imperative for Creating and Profiting from Technology. Harvard Business School Press, Massachusetts.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Lin H, Zeng S, Chen Y, et al., 2024, Absorptive Capacity in Open Innovation: The Role of External Knowledge Diversity. Journal of International Business Studies, 55(1): 123–145.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Barney J, 1991, Firm Resources and Sustained Competitive Advantage. Journal of Management, 17(1): 99–120.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Wang S, Moore G, 2024, Knowledge Protection in the Open Resource-Based View: Identity, Boundaries, and Absorptive Capacity. Journal of Business Venturing, 39(2): 215–238.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Cathay Industrial Biotech’s Prospectus, 2020, Cathay Industrial Biotech’s Prospectus (July 2020). Cathay Industrial Biotech.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Genomatica, 2026, Crunchbase Funding Database, visited on January 12, 2026, https://www.crunchbase.com/organization/genomatica.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
